VAXY LIMITED

Company Registration Number:
13194462 (England and Wales)

Unaudited micro entity accounts for the year ended 28 February 2025

Period of accounts

Start date: 01 March 2024

End date: 28 February 2025

VAXY LIMITED

Contents of the Financial Statements

for the Period Ended 28 February 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

VAXY LIMITED

Company Information

for the Period Ended 28 February 2025




Director: Sisira Pushpa Kumara WEERASINGHE
Registered office: 25
Enfield Road
Brentford
England
TW8 9NY
Company Registration Number: 13194462 (England and Wales)

VAXY LIMITED

Directors' Report Period Ended 28 February 2025

The directors present their report with the financial statements of the company for the period ended 28 February 2025

Principal Activities

The company's principal activity during the year was retail sale via mail order houses or via Internet.

Political and charitable donations

No political donations were made.

Directors

The directors shown below have held office during the whole of the period from 01 March 2024 to 28 February 2025
Sisira Pushpa Kumara WEERASINGHE

This report was approved by the board of directors on 29 May 2025
And Signed On Behalf Of The Board By:

Name: Sisira Pushpa Kumara WEERASINGHE
Status: Director

VAXY LIMITED

Profit and Loss Account

for the Period Ended 28 February 2025


2025
£

2024
£
Turnover 70,389 108,927
Cost of Materials ( 55,223 ) ( 17,491 )
Staff Costs ( 25,152 ) ( 13,717 )
Other charges ( 23,747 ) ( 76,925 )
Tax on Profit - ( 151 )
Profit or (Loss) for Period ( 33,733 ) 643

VAXY LIMITED

Balance sheet

As at 28 February 2025


2025
£

2024
£
Current assets: 26,179 34,282
Creditors: amounts falling due within one year: ( 0 ) ( 33,639 )
Net current assets (liabilities): 26,179 643
Total assets less current liabilities: 26,179 643
Total net assets (liabilities): 26,179 643
Capital and reserves: 26,179 643

VAXY LIMITED

Balance sheet continued

For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 29 May 2025
And Signed On Behalf Of The Board By:

Name: Sisira Pushpa Kumara WEERASINGHE
Status: Director

The notes form part of these financial statements

VAXY LIMITED

Footnotes to the Financial Statements

for the Period Ended 28 February 2025

  • 1. Employee Information

    Average number of employees: 1

VAXY LIMITED

Footnotes to the Financial Statements

for the Period Ended 28 February 2025

  • 2. Off balance sheet disclosure

    No